Alcon AG | ALC - Assets


Alcon AG reported $31.1B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AstraZeneca USD 119.92B 4.09B Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Essilor EUR 65.06B 1.16B Jun/2026
Fresenius EUR 42.24B 401M Sep/2026
Fresenius Medical Care EUR 31.45B 155.97M Sep/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Novartis USD 117.15B 4.88B Sep/2026
Philips EUR 28.03B 1.33B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Smith & Nephew USD 11.01B 321M Jun/2026
Sonova Holding CHF 5.92B 468.2M Jun/2025
UCB EUR 18.16B 971M Dec/2025